Bharath Venkatram

Senior Engineer - Process Development & Scale up Lab Amgen Inc.

Seminars

Wednesday 19th August 2026
Speaker Q&A: What Breaks First When You Scale Oligos from IND to Commercial?
10:00 am
  • Which early-stage assumptions around CPPs and impurity control most commonly fail at commercial scale?
  • How to predict the point where oligo impurity complexity outpaces the existing analytical control strategy?
  • What elements of process design, raw material qualification, or method validation are most frequently reworked post-Phase II, and why?
Bharath Venkatram-Assaf - Expert Speaker - 5th Oligonucleotides Analytical Development & CMC